Univariate modelling determined that 5T4 expression (p = 0.006), CXCL12 expression [34] (p = 0.026), adjuvant therapy (p = 0.003), FIGO staging (p < 0.001), tumour grade (p = 0.001) and histotype (p < 0.001) were significantly associated with cancer-specific survival in this cohort (Table 3). The gene discussed is CXCL12; the disease is cancer.